CDC committee: HPV vaccine could benefit adults up to 45
June 27, 2019
Men and women as old as 45 could benefit from receiving the human papillomavirus vaccine, the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices voted June 26.
While the HPV vaccine is recommended for boys and girls during adolescence, this new recommendation states patients between the ages of 27 and 45 who have not been vaccinated adequately should discuss with their physician whether catch-up vaccination is right for them.
The Food and Drug Administration previously approved the use of the vaccine in men and women ages 27 to 45 in October 2018.
The committee also voted to recommend catch-up vaccination for men through the age of 26 to align with its recommendations for women. This previously had been recommended for most men only through age 21.
The ADA in 2018 adopted a policy that urges dentists to support the use and administration of the HPV vaccine, recognizing it as a way to help prevent infection of the types of HPV associated with oropharyngeal cancer. The vaccine could prevent nearly 90% of HPV-related cancers in the U.S.
The ADA also released a brochure on the vaccine in April. "Oral Health and the HPV Vaccine" provides patients with basic information about the HPV vaccine, including CDC recommendations on those who should get the vaccine and dosage timing and amount, vaccine safety, signs and symptoms of oropharyngeal cancer, and a simple illustration of the oropharynx.
To read more about oral and oropharyngeal cancer, including HPV-associated oropharyngeal cancer and ADA policy on the HPV vaccine, visit ADA.org/en/member-center/oral-health-topics/cancer-head-and-neck.
At ADA FDI World Dental Congress Sept. 4-8 in San Francisco, Dr. Alessandro Villa of the Harvard School of Dental Medicine and Brigham and Women's Hospital will present a continuing education course on "HPV Vaccination and the Oral Health Care Community."
In the course, dentists will learn about the risk factors, signs and symptoms of HPV-associated oropharyngeal carcinoma, understand the importance of the current HPV vaccination series and learn effective ways to communicate HPV vaccine recommendations to patients.
To register for the congress, go to ADA.org/meeting.